Lexaria Bioscience Corp. — All Filings
1,000 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-KT
10-Q
10-Q/A
10KSB
10KSB/A
10QSB
25-NSE
3
4
4/A
424B3
424B4
424B5
8-A12B
8-A12G
8-K
8-K/A
CERT
CORRESP
CT ORDER
D
DEF 14A
DEF 14C
DEFA14A
DRS
EFFECT
NT 10-K
NTN 10K
POS AM
PRE 14A
RW
S-1
S-1/A
S-1MEF
S-3
S-4
S-4/A
S-8
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | PRIMARY DOCUMENT | 0001855763-24-000005 | May 10, 2024 | Apr 26, 2024 |
| D | — | 0001855763-24-000003 | May 2, 2024 | — |
| 8-K | FORM 8-K | 0001640334-24-000708 | Apr 30, 2024 | — |
| SC 13D/A | SCHEDULE 13D/A | 0001235126-24-000023 | Apr 25, 2024 | — |
| 8-K | FORM 8-K | 0001640334-24-000702 | Apr 24, 2024 | Apr 23, 2024 |
| 10-Q | FORM 10-Q | 0001640334-24-000589 | Apr 9, 2024 | Feb 29, 2024 |
| 8-K | FORM 8-K | 0001640334-24-000446 | Mar 21, 2024 | Mar 15, 2024 |
| 424B3 | FORM 424B3 | 0001640334-24-000431 | Mar 20, 2024 | — |
| EFFECT | — | 9999999995-24-000695 | Mar 20, 2024 | — |
| UPLOAD | — | 0000000000-24-002914 | Mar 18, 2024 | — |
| CORRESP | — | 0001640334-24-000412 | Mar 18, 2024 | — |
| 3 | PRIMARY DOCUMENT | 0001855763-24-000002 | Mar 15, 2024 | Mar 14, 2024 |
| 8-K | FORM 8-K | 0001640334-24-000410 | Mar 15, 2024 | Mar 14, 2024 |
| S-1 | FORM S-1 | 0001640334-24-000388 | Mar 12, 2024 | — |
| DEF 14A | DEF 14A | 0001640334-24-000357 | Mar 6, 2024 | Feb 27, 2024 |
| 8-K | FORM 8-K | 0001640334-24-000328 | Mar 1, 2024 | Feb 29, 2024 |
| D | — | 0001855763-24-000001 | Feb 16, 2024 | — |
| 8-K | FORM 8-K | 0001640334-24-000271 | Feb 16, 2024 | Feb 14, 2024 |
| 424B5 | 424B5 | 0001640334-24-000265 | Feb 16, 2024 | — |
| SC 13D/A | SCHEDULE 13D-A | 0001235126-24-000010 | Feb 14, 2024 | — |
| SC 13G/A | AMENDMENT NO. 2 | 0001214659-24-002623 | Feb 14, 2024 | — |
| 8-K | FORM 8-K | 0001640334-24-000167 | Jan 30, 2024 | Jan 29, 2024 |
| EFFECT | — | 9999999995-24-000222 | Jan 26, 2024 | — |
| POS AM | POS AM | 0001640334-24-000134 | Jan 24, 2024 | — |
| 8-K | FORM 8-K | 0001640334-24-000137 | Jan 24, 2024 | — |
| S-8 | FORM S-8 | 0001640334-24-000086 | Jan 18, 2024 | — |
| 10-Q | FORM 10-Q | 0001640334-24-000051 | Jan 12, 2024 | Nov 30, 2023 |
| 8-K | FORM 8-K | 0001640334-24-000007 | Jan 4, 2024 | — |
| 424B3 | FORM 424B3 | 0001640334-23-002286 | Dec 8, 2023 | — |
| EFFECT | — | 9999999995-23-003580 | Dec 8, 2023 | — |
| CORRESP | — | 0001640334-23-002271 | Dec 6, 2023 | — |
| UPLOAD | — | 0000000000-23-013268 | Dec 6, 2023 | — |
| S-1 | FORM S-1 | 0001640334-23-002255 | Nov 30, 2023 | — |
| 10-K | FORM 10-K | 0001640334-23-002227 | Nov 20, 2023 | Aug 31, 2023 |
| 8-K | FORM 8-K | 0001640334-23-002017 | Nov 3, 2023 | — |
| 4 | PRIMARY DOCUMENT | 0001855763-23-000009 | Nov 1, 2023 | Oct 26, 2023 |
| 4 | PRIMARY DOCUMENT | 0001855763-23-000007 | Oct 30, 2023 | Oct 26, 2023 |
| 4 | PRIMARY DOCUMENT | 0001855763-23-000008 | Oct 30, 2023 | Oct 26, 2023 |
| 8-K | FORM 8-K | 0001640334-23-001869 | Oct 18, 2023 | Oct 17, 2023 |
| 8-K | FORM 8-K | 0001640334-23-001846 | Oct 16, 2023 | Oct 3, 2023 |
| 8-K | FORM 8-K | 0001640334-23-001812 | Oct 12, 2023 | Oct 10, 2023 |
| D | — | 0001855763-23-000006 | Oct 4, 2023 | — |
| 8-K | FORM 8-K | 0001640334-23-001769 | Oct 3, 2023 | Sep 28, 2023 |
| 424B5 | 424B5 | 0001640334-23-001756 | Oct 2, 2023 | — |
| SC 13D | SCHEDULE 13D | 0001987877-23-000002 | Sep 18, 2023 | — |
| 8-K | FORM 8-K | 0001640334-23-001644 | Aug 28, 2023 | Aug 24, 2023 |
| DEF 14A | DEF 14A | 0001640334-23-001621 | Aug 23, 2023 | Aug 8, 2023 |
| PRE 14A | PRE 14A | 0001640334-23-001495 | Aug 9, 2023 | Aug 8, 2023 |
| 8-K | FORM 8-K | 0001640334-23-001375 | Jul 28, 2023 | Jul 26, 2023 |
| 4 | PRIMARY DOCUMENT | 0001855763-23-000005 | Jul 25, 2023 | — |